Evidence map›Paper›PMID 33887234›Full record

ArticleAnalytical biochemistry2021

A continuous flow cell culture system for precision cell stimulation and time-resolved profiling of cell secretion.

Patrick Erickson, Tony Houwayek, Alexandra Burr, Matthew Teryek, Biju Parekkadan

Abstract read
In one paragraph

Article in Analytical biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. A cell culture system to model pharmacokinetics using adjustable-volume perfused mixing chambers.Toxicology in vitro : an international journal published in association with BIBRA · 2023
    Article
  4. Article
  5. Allometric-like scaling of AAV gene therapy for systemic protein delivery.Molecular therapy. Methods & clinical development · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Patrick EricksonDepartment of Chemical and Biochemical Engineering, Rutgers University, Piscataway, NJ, 08854, USA.
Tony HouwayekDepartment of Biomedical Engineering, Rutgers University, Piscataway, NJ, 08854, USA.
Alexandra BurrDepartment of Biomedical Engineering, Rutgers University, Piscataway, NJ, 08854, USA.
Matthew TeryekDepartment of Biomedical Engineering, Rutgers University, Piscataway, NJ, 08854, USA.
Biju ParekkadanDepartment of Biomedical Engineering, Rutgers University, Piscataway, NJ, 08854, USA; Department of Medicine, Rutgers Biomedical Health Sciences, New Brunswick, NJ, 08852, USA. Electronic address: biju.parekkadan@rutgers.edu.

Funding

X-RAY STRUCTURE OF RIFM PROTEIN FROM THE BIOSYNTHESIS PATHWAY OF THE ANSAMYCIN AP41RR012408 · NCRR · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MARIUZZA, ROY A · 1998 to 2011
$32.2M
UMDNJ TRAINING GRANT IN BIOTECHNOLOGYT32GM008339 · NIGMS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI YARMUSH, MARTIN L · 1989 to 2019
$6.1M
Artificial, Humanized Stem Cell NichesR01EB012521 · NIBIB · RUTGERS, THE STATE UNIV OF N.J. · PI PAREKKADAN, BIJU · 2011 to 2021
$6.0M
Rutgers Biotechnology Training ProgramT32GM135141 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI ANN M. STOCK, Martin L Yarmush · 2020 to 2026
$3.5M
A Functional genomics platform with integrated library cloning and molecular displayR01GM127353 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI LARMAN, HARRY BENJAMIN, PAREKKADAN, BIJU · 2018 to 2021
$1.4M
Theranostic approach to transplant rejection using engineered cell biosensorsR21AI134116 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI PAREKKADAN, BIJU, UYGUN, KORKUT · 2018 to 2019
$463k
NCRR NIH HHS P41 RR012408NIAID NIH HHS R21 AI134116NIBIB NIH HHS R01 EB012521NIGMS NIH HHS R01 GM127353NIGMS NIH HHS T32 GM008339NIGMS NIH HHS T32 GM135141
6 · The paper itself

Abstract

Cells exchange substances with their surroundings during metabolism, signaling, and other functions. These fluxes are dynamic, changing in response to external cues and internal programs. Static cultures are inadequate for measuring these dynamics because the environments of the cells change as substances accumulate or deplete from medium, unintentionally affecting cell behavior. Static cultures offer limited time resolution due to the impracticality of frequent or prolonged manual sampling, and cannot expose cells to smooth, transient changes in stimulus concentrations. In contrast, perfusion cultures constantly maintain cellular environments and continuously sample the effluent stream. Existing perfusion culture systems are either microfluidic, which are difficult to make and use, or macrofluidic devices built from custom parts that neglect solute dispersion. In this study, a multiplexed macrofluidic perfusion culture platform was developed to measure secretion and absorption rates of substances by cells in a temporally controlled environment. The modular platform handles up to 31 streams with automated fraction collection. This paper presents the assembly of this dynamic bioreactor from commercially available parts, and a method for quantitatively handling the effects of dispersion using residence time distributions. The system is then applied to monitor the secretion of a circadian clock gene-driven reporter from engineered cells.

Indexed as

BioreactorsCell Physiological PhenomenaCell Culture TechniquesCells, CulturedCell SurvivalCulture MediaCulture MediaBioreactorCircadianDynamicsResidence time distributionSecretionStimulation

Identifiers

PMID33887234
PMCPMC8154734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.